Procept BioroboticsPRCT
About: PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AquaBeam Robotic System,, image-guided, surgical robotic system for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. The company's assets are based in the United States. Its revenue is generated from sales of the AquaBeam Robotic System and the accompanying single-use disposable handpieces.
Employees: 626
Fund manager confidence
Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)
300% more funds holding in top 10
Funds holding in top 10: 2 [Q1] → 8 (+6) [Q2]
231% more first-time investments, than exits
New positions opened: 53 | Existing positions closed: 16
47% more repeat investments, than reductions
Existing positions increased: 75 | Existing positions reduced: 51
23% more funds holding
Funds holding: 161 [Q1] → 198 (+37) [Q2]
18% more capital invested
Capital invested by funds: $2.28B [Q1] → $2.68B (+$407M) [Q2]
1% more call options, than puts
Call options by funds: $20.1M | Put options by funds: $20M
5.27% less ownership
Funds ownership: 90.69% [Q1] → 85.42% (-5.27%) [Q2]
Research analyst outlook
6 Wall Street Analysts provided 1 year price targets over the past 3 months
6 analyst ratings
Piper Sandler Matt O'Brien 40% 1-year accuracy 18 / 45 met price target | 9%upside $75 | Overweight Reiterated | 8 Oct 2024 |
TD Cowen Joshua Jennings 44% 1-year accuracy 4 / 9 met price target | 43%upside $99 | Buy Maintained | 16 Sept 2024 |
Truist Securities Richard Newitter 68% 1-year accuracy 27 / 40 met price target | 38%upside $95 | Buy Maintained | 3 Sept 2024 |
B of A Securities Craig Bijou 67% 1-year accuracy 4 / 6 met price target | 36%upside $94 | Buy Maintained | 22 Aug 2024 |
Wells Fargo Nathan Treybeck 100% 1-year accuracy 4 / 4 met price target | 0%downside $69 | Overweight Maintained | 2 Aug 2024 |
Financial journalist opinion
Based on 3 articles about PRCT published over the past 30 days